Cancer clinical trials often involve high-risk patients and experimental therapies that can have severe side effects. A DMC ensures the safety of participants by periodically reviewing the data collected during the trial. This independent oversight helps in early detection of adverse effects and ensures that the trial can be modified or stopped if necessary to protect the patients.
